Mylan launches generic version of Trilipix

PITTSBURGH — Mylan has launched a generic drug for treating cholesterol problems, the company said Monday.

Mylan announced the launch of generic fenofibric acid delayed-release capsules in the 45-mg and 135-mg strengths.

The drug is a generic version of Abbott's Trilipix, designed for use in combination with statin drugs and diet to reduce triglycerides and increase high-density lipoprotein or "good" cholesterol.

Various versions of the drug had sales of about $553.6 million during the 12-month period that ended in March, according to IMS Health.